晶瑞股份(300655.SZ):一期年產3萬噸超大規模集成電路用半導體級高純硫酸技改項目已建設完工
格隆匯5月12日丨晶瑞股份(300655.SZ)公佈,為助推國家核心競爭力,拓展公司核心領域產品序列,公司於2020年6月啟動了年產9萬噸超大規模集成電路用半導體級高純硫酸技改項目。同時,為進一步提升項目建設及運營管理效率,該項目採用分期方式予以投建實施。一期建設項目設計年產能3萬噸,總投資18742.13萬元。
截至目前,一期年產3萬噸超大規模集成電路用半導體級高純硫酸技改項目已完成項目備案、環境影響評價批覆等程序。項目全部工程已建設完工,項目所需設備已購置並安裝、調試完畢,運行穩定。經近期試生產調試,公司半導體級高純硫酸產品金屬雜質含量低於10ppt,達到G5級水平,品質已達全球同行業第一梯隊水平,產品技術指標可以履蓋目前全部先進集成電路技術節點的要求,符合公司預期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.